Skip to main content

Table 3 Proportion of positive total anti-N antibody tests by epidemiological wave

From: SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City

Wave

Sample 1 (n = 764)

Sample 2 (n = 645)

Total

 

n

%

n

%

n

%

First

29/178

16.3

0/2

0

29/180

16.1

Second

173/538

32.2

92/207

44.4

265/745

35.5

Third

19/48

39.6

207/436

47.4

226/484

46.6

  1. For this analysis, samples obtained out of the timeframes of the epidemiological waves (n = 34 for sample 1 and n = 155 for sample 2) were excluded
  2. aFirst wave: 2020/02/16 to 2020/09/26
  3. bSecond wave: 2020/09/27 to 2021/04/17
  4. cThird wave: 2021/06/06 to 2021/09/23
Back to article page

Virology Journal

ISSN: 1743-422X